Mirikizumab Beats Placebo, Secukinumab for Psoriasis ...Middle East

News by : (Medscape) -
52-week trial data pitting an interleukin-23 drug against an IL-17 inhibitor and placebo offers insight on efficacy and safety. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirikizumab Beats Placebo, Secukinumab for Psoriasis )

Also on site :

Most Viewed News
جديد الاخبار